Tag: Semler Stock

  • Semler Scientific (SMLR) Soars In Pre-Hour Trading Following Bold BTC Strategy

    Semler Scientific (SMLR) Soars In Pre-Hour Trading Following Bold BTC Strategy

    Semler Scientific, Inc. (NASDAQ: SMLR) shares are experiencing a notable growth following the announcement of its strategic focus on digital assets. As of the latest pre-market check, SMLR stock price surged by 15.99%, reaching $68.75, continuing a strong upward trajectory with a more than 25% increase over the past five days.

    Key Bitcoin Purchases and Holdings

    Semler Scientific (SMLR) has announced updates on its bitcoin-related operations, emphasizing noteworthy acquisitions. At an average price of $82,502 per bitcoin, SMLR paid $17.7 million for 215 bitcoins between November 6 and November 15, 2024. With an average purchase price of $69,682 per bitcoin, this increases its total bitcoin holdings to 1,273 BTC, which were acquired for a total of $88.7 million.

    Capital Markets Activity and Strategic Sales

    The company also disclosed its capital markets activities, revealing that since the effective date of its registration statement on August 13, 2024, it has raised $21.5 million through the sale of 505,544 shares under a Controlled Equity Offering Sales Agreement with Cantor Fitzgerald & Co. This funding supports Semler Scientific’s strategy of using equity capital to finance its bitcoin purchases, further solidifying its position in the digital asset market.

    BTC Yield: A Key Performance Indicator

    A critical performance metric for Semler Scientific has been its BTC Yield, which reflects the success of its bitcoin investment strategy. SMLR reported an impressive 18.9% BTC Yield from October 1 to November 15, 2024. More notably, since the adoption of its bitcoin treasury strategy in the second quarter of 2024, Semler achieved a BTC Yield of 37.3%.

    This KPI, which Semler Scientific believes demonstrates the positive impact of its bitcoin strategy on stockholder value, has become an essential part of its broader financial performance evaluation. SMLR’s bold foray into digital assets has resulted in substantial returns, bolstering investor confidence and positioning the company for continued growth.

  • Strategic Shift Bolsters Semler Scientific’s (SMLR) Stock Performance

    Strategic Shift Bolsters Semler Scientific’s (SMLR) Stock Performance

    The stock price of Semler Scientific, Inc. (NASDAQ: SMLR) saw a notable increase in response to a newly disclosed strategic decision. After-hours trading saw SMLR shares rise 11.03% to $32.20 in response to the announcement, continuing the 24.36% gain that they had made during the regular session, which ended at $29.00.

    Using Bitcoin As A Reserve Asset For The Treasury

    Semler Scientific (SMLR) has decided to utilize bitcoin as the company’s primary treasury reserve asset. Once fees and penalties are subtracted, the company has invested $40 million to buy 581 bitcoins. This decision of its board of directors reflects Semler Scientific’s conviction that bitcoin is a reliable store of wealth and a sound investment.

    Semler Scientific believes that the distinctive qualities like its limited supply and scarcity make bitcoin a sensible hedge against inflation and a safe haven in times of world unrest. With a market value of more than $1 trillion, bitcoin is well-positioned to provide significant profits as more people recognize it as the digital version of gold.

    Adoption By Institutions And Its Consequences For Strategy

    The growing institutional adoption of bitcoin has further energized Semler Scientific’s commitment to this strategy. Recent approval by the Securities and Exchange Commission of 11 bitcoin exchange-traded funds (ETFs) in January 2024 has led to over $13 billion in net inflows from nearly 1,000 institutions, including pensions, endowments, registered investment advisors as well as global banks. It is estimated that institutional holdings now account for more than 10% of all bitcoins.

    Focus On Core Medical Products

    Semler Scientific is committed to its primary business activities in spite of this renewed emphasis on bitcoin. Sales of QuantaFlo, its diagnostic tool for assessing peripheral artery disease, remain Semler Scientific’s top priority. Semler Scientific is also requesting a fresh approval from the FDA to broaden the product’s label to include the diagnosis of additional cardiovascular conditions.

    The objective of this well-rounded strategy is to capitalize on the advantages of bitcoin while preserving and improving the business’s well-known medical goods and services.